Arsela Prelaj: Early NSCLC Strategies on IO and Targeted Therapies at the ESMO Advanced Course
Arsela Prelaj/X

Arsela Prelaj: Early NSCLC Strategies on IO and Targeted Therapies at the ESMO Advanced Course

Arsela Prelaj, Medical Oncologist and PhD in Bioengineering, Head of AI-ON-Lab (Artificial Intelligence Lab) at IRCCS Foundation National Cancer Institute, shared a post on X:

“Amazing days organzied by ESMO with exellent chairs like Helena Linardou, Giannis Mountzios and Solange Peters in the Fantastic Greece on Early NSCLC strategies on IO and target therapies:

Workshops and AI: around 70 participants from around Europe.”

Arsela Prelaj: Early NSCLC Strategies on IO and Targeted Therapies at the ESMO Advanced Course

More posts about ESMO.